These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29061473)

  • 1. Optimization of ultra-high pressure liquid chromatography - tandem mass spectrometry determination in plasma and red blood cells of four sphingolipids and their evaluation as biomarker candidates of Gaucher's disease.
    Chipeaux C; de Person M; Burguet N; Billette de Villemeur T; Rose C; Belmatoug N; Héron S; Le Van Kim C; Franco M; Moussa F
    J Chromatogr A; 2017 Nov; 1525():116-125. PubMed ID: 29061473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sphingolipids overload on red blood cell properties in Gaucher disease.
    Dupuis L; Chipeaux C; Bourdelier E; Martino S; Reihani N; Belmatoug N; Billette de Villemeur T; Hivert B; Moussa F; Le Van Kim C; de Person M; Franco M
    J Cell Mol Med; 2020 Sep; 24(17):9726-9736. PubMed ID: 32767726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a new online SPE-HPLC-MS/MS method for the profiling and quantification of sphingolipids and phospholipids in red blood cells - Application to the study of Gaucher's disease.
    Bettioui T; Chipeaux C; Ben Arfa K; Héron S; Belmatoug N; Franco M; de Person M; Moussa F
    Anal Chim Acta; 2023 Oct; 1278():341719. PubMed ID: 37709430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study.
    Polo G; Burlina AP; Ranieri E; Colucci F; Rubert L; Pascarella A; Duro G; Tummolo A; Padoan A; Plebani M; Burlina AB
    Clin Chem Lab Med; 2019 Nov; 57(12):1863-1874. PubMed ID: 31091195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantitation of sphingoid bases by UPLC-ESI-MS/MS with identical
    Mirzaian M; Wisse P; Ferraz MJ; Marques ARA; Gaspar P; Oussoren SV; Kytidou K; Codée JDC; van der Marel G; Overkleeft HS; Aerts JM
    Clin Chim Acta; 2017 Mar; 466():178-184. PubMed ID: 28089753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS/MS.
    Tang C; Jia X; Tang F; Liu S; Jiang X; Zhao X; Sheng H; Peng M; Liu L; Huang Y
    Clin Biochem; 2021 Jan; 87():79-84. PubMed ID: 33188770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Lysosphingolipid Biomarker Measurement by Liquid Chromatography Tandem Mass Spectrometry.
    Stauffer BB; Yu C
    Methods Mol Biol; 2022; 2546():271-284. PubMed ID: 36127597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of sphingosine-1-phosphate and related sphingolipids by liquid chromatography coupled to tandem mass spectrometry.
    Bode C; Gräler MH
    Methods Mol Biol; 2012; 874():33-44. PubMed ID: 22528437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF.
    Vernet Machado Bressan Wilke M; Iop GD; Faqueti L; Lemos da Silva LA; Kubaski F; Poswar FO; Michelin-Tirelli K; Randon D; Borelli WV; Giugliani R; Schwartz IVD
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scaled human serum sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: method development and application in hepatocellular carcinoma.
    Li J; Hu C; Zhao X; Dai W; Chen S; Lu X; Xu G
    J Chromatogr A; 2013 Dec; 1320():103-10. PubMed ID: 24210299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry.
    Lan T; Bi H; Liu W; Xie X; Xu S; Huang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(7-8):520-6. PubMed ID: 21292568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A validated ultra-high-performance liquid chromatography-tandem mass spectrometry method for the selective analysis of free and total folate in plasma and red blood cells.
    Kiekens F; Van Daele J; Blancquaert D; Van Der Straeten D; Lambert WE; Stove CP
    J Chromatogr A; 2015 Jun; 1398():20-8. PubMed ID: 25937128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Reliable Biomarker Profile for the Diagnosis of Gaucher Disease Type 1 Patients Using a Mass Spectrometry-Based Metabolomic Approach.
    Menkovic I; Boutin M; Alayoubi A; Mercier FE; Rivard GÉ; Auray-Blais C
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid evaluation of 25 key sphingolipids and phosphosphingolipids in human plasma by LC-MS/MS.
    Basit A; Piomelli D; Armirotti A
    Anal Bioanal Chem; 2015 Jul; 407(17):5189-98. PubMed ID: 25749796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple and rapid method for extraction and measurement of circulating sphingolipids using LC-MS/MS: a targeted lipidomic analysis.
    Xu Y; Li H; Han Y; Wang T; Wang Y; Gong J; Gao K; Chen W; Li W; Zhang H; Wang J; Qiu X; Zhu T
    Anal Bioanal Chem; 2022 Mar; 414(6):2041-2054. PubMed ID: 35066602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials.
    Elstein D; Mellgard B; Dinh Q; Lan L; Qiu Y; Cozma C; Eichler S; Böttcher T; Zimran A
    Mol Genet Metab; 2017 Sep; 122(1-2):113-120. PubMed ID: 28851512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of Antiviral Drugs and Their Metabolites Using Micro-Solid Phase Extraction and UHPLC-MS/MS in Reversed-Phase and Hydrophilic Interaction Chromatography Modes.
    Fical L; Khalikova M; Kočová Vlčková H; Lhotská I; Hadysová Z; Vokřál I; Červený L; Švec F; Nováková L
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33917128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS.
    Polo G; Burlina AP; Kolamunnage TB; Zampieri M; Dionisi-Vici C; Strisciuglio P; Zaninotto M; Plebani M; Burlina AB
    Clin Chem Lab Med; 2017 Mar; 55(3):403-414. PubMed ID: 27533120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucosylsphingosine is a key biomarker of Gaucher disease.
    Murugesan V; Chuang WL; Liu J; Lischuk A; Kacena K; Lin H; Pastores GM; Yang R; Keutzer J; Zhang K; Mistry PK
    Am J Hematol; 2016 Nov; 91(11):1082-1089. PubMed ID: 27441734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic evaluation of matrix effects in hydrophilic interaction chromatography versus reversed phase liquid chromatography coupled to mass spectrometry.
    Periat A; Kohler I; Thomas A; Nicoli R; Boccard J; Veuthey JL; Schappler J; Guillarme D
    J Chromatogr A; 2016 Mar; 1439():42-53. PubMed ID: 26387791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.